Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

45.40
BRL
-1.00
(-2.16%)
5.14EPS
12.36P/E
175.47BMarket Cap
Feb 18Next Earn

Alnylam Pharmaceuticals, Inc. Documents

Q2 FY2024 · Quarterly report

78 pages

Read Alnylam Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2024 documents